| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | GABRB1 KCNH6 SLC26A3 SIDT2 TMEM184A SLC16A3 ABCA12 PIEZO1 ABCC11 LRP5 ATP13A5 BCL2 SLC45A1 TMEM184B ANO3 SLC2A1 SLC16A8 SLC5A3 SLC5A4 | 4.70e-09 | 1289 | 61 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 KCNH6 SLC26A3 SIDT2 SLC16A3 ABCA12 PIEZO1 ABCC11 LRP5 ATP13A5 BCL2 SLC45A1 ANO3 SLC2A1 SLC16A8 SLC5A3 SLC5A4 | 5.25e-08 | 1180 | 61 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 9.50e-07 | 25 | 61 | 4 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 9.50e-07 | 25 | 61 | 4 | GO:0015149 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.31e-06 | 27 | 61 | 4 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.77e-06 | 29 | 61 | 4 | GO:0051119 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR1N2 GABRB1 OR51A4 OR51A2 TAS2R10 RXFP2 OR10V1 OR1P1 OR10A6 OR1K1 OR5A1 RXFP1 OR1L3 | 2.10e-06 | 884 | 61 | 13 | GO:0004930 |
| GeneOntologyMolecularFunction | olfactory receptor activity | 6.01e-06 | 431 | 61 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 8.09e-06 | 42 | 61 | 4 | GO:0015144 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC26A3 SLC16A3 ABCA12 ABCC11 ATP13A5 SLC45A1 SLC16A8 SLC5A3 SLC5A4 | 1.35e-05 | 477 | 61 | 9 | GO:0022804 |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 1.79e-05 | 17 | 61 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR1N2 GABRB1 OR51A4 OR51A2 TAS2R10 RXFP2 OR10V1 OR1P1 OR10A6 LRP5 OR1K1 OR5A1 RXFP1 OR1L3 | 4.44e-05 | 1353 | 61 | 14 | GO:0004888 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 6.22e-05 | 70 | 61 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | symporter activity | 9.49e-05 | 150 | 61 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 KCNH6 SLC26A3 SLC16A3 PIEZO1 ATP13A5 SLC45A1 ANO3 SLC5A3 SLC5A4 | 1.33e-04 | 793 | 61 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | lactate transmembrane transporter activity | 1.37e-04 | 6 | 61 | 2 | GO:0015129 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.65e-04 | 90 | 61 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 1.91e-04 | 7 | 61 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.82e-04 | 296 | 61 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 3.09e-04 | 301 | 61 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 3.26e-04 | 9 | 61 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.24e-04 | 207 | 61 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.33e-04 | 208 | 61 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 KCNH6 SLC26A3 SLC16A3 ABCC11 SLC45A1 ANO3 SLC5A3 SLC5A4 | 4.61e-04 | 758 | 61 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.81e-04 | 119 | 61 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | G protein activity | 7.81e-04 | 59 | 61 | 3 | GO:0003925 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipid binding | 8.20e-04 | 60 | 61 | 3 | GO:0005544 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.45e-03 | 73 | 61 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.85e-03 | 171 | 61 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.00e-03 | 293 | 61 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.37e-03 | 775 | 61 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 2.63e-03 | 25 | 61 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.04e-03 | 196 | 61 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 3.85e-03 | 839 | 61 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | GDP binding | 3.86e-03 | 103 | 61 | 3 | GO:0019003 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 3.88e-03 | 840 | 61 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.88e-03 | 840 | 61 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 4.01e-03 | 664 | 61 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 4.53e-03 | 109 | 61 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 4.84e-03 | 34 | 61 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 4.84e-03 | 34 | 61 | 2 | GO:0017147 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 6.62e-03 | 125 | 61 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | odorant binding | 6.91e-03 | 127 | 61 | 3 | GO:0005549 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 8.35e-03 | 45 | 61 | 2 | GO:0043495 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 9.84e-03 | 49 | 61 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 9.84e-03 | 49 | 61 | 2 | GO:0048487 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.02e-02 | 50 | 61 | 2 | GO:0099095 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.06e-02 | 51 | 61 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.11e-02 | 151 | 61 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.11e-02 | 441 | 61 | 5 | GO:0016887 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR1N2 OR51A4 OR51A2 TAS2R10 PIEZO1 OR10V1 OR1P1 OR10A6 OR1K1 OR5A1 ANO3 OR1L3 | 1.11e-06 | 722 | 61 | 12 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR1N2 OR51A4 OR51A2 TAS2R10 OR10V1 OR1P1 OR10A6 OR1K1 OR5A1 OR1L3 | 1.45e-06 | 485 | 61 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR1N2 OR51A4 OR51A2 TAS2R10 OR10V1 OR1P1 OR10A6 OR1K1 OR5A1 OR1L3 | 2.90e-06 | 524 | 61 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR1N2 OR51A4 OR51A2 TAS2R10 OR10V1 OR1P1 OR10A6 OR1K1 OR5A1 OR1L3 | 4.24e-06 | 547 | 61 | 10 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 4.72e-06 | 432 | 61 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR1N2 OR51A4 OR51A2 TAS2R10 OR10V1 OR1P1 OR10A6 OR1K1 OR5A1 OR1L3 | 7.31e-06 | 582 | 61 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception of smell | 8.54e-06 | 465 | 61 | 9 | GO:0007608 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast proliferation | 1.38e-04 | 34 | 61 | 3 | GO:0033688 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.82e-04 | 178 | 61 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | osteoblast proliferation | 2.42e-04 | 41 | 61 | 3 | GO:0033687 | |
| GeneOntologyBiologicalProcess | lactate transport | 3.06e-04 | 9 | 61 | 2 | GO:0015727 | |
| GeneOntologyBiologicalProcess | lactate transmembrane transport | 3.06e-04 | 9 | 61 | 2 | GO:0035873 | |
| HumanPheno | Linear nevus sebaceous | 6.99e-08 | 3 | 22 | 3 | HP:0010817 | |
| HumanPheno | Hemimegalencephaly | 2.54e-07 | 14 | 22 | 4 | HP:0007206 | |
| HumanPheno | Lymphedema | 5.58e-07 | 76 | 22 | 6 | HP:0001004 | |
| HumanPheno | Cranial asymmetry | 5.99e-07 | 17 | 22 | 4 | HP:0000267 | |
| HumanPheno | Nevus sebaceous | 6.96e-07 | 5 | 22 | 3 | HP:0010815 | |
| HumanPheno | Epidermal nevus | 1.50e-05 | 12 | 22 | 3 | HP:0010816 | |
| HumanPheno | Megalencephaly | 3.16e-05 | 44 | 22 | 4 | HP:0001355 | |
| HumanPheno | Nevus spilus | 5.33e-05 | 3 | 22 | 2 | HP:0025510 | |
| HumanPheno | Premature birth | 7.59e-05 | 177 | 22 | 6 | HP:0001622 | |
| HumanPheno | Prominent occiput | 1.24e-04 | 62 | 22 | 4 | HP:0000269 | |
| HumanPheno | Hemihypertrophy | 1.51e-04 | 25 | 22 | 3 | HP:0001528 | |
| HumanPheno | Adenoma sebaceum | 1.51e-04 | 25 | 22 | 3 | HP:0009720 | |
| HumanPheno | Hypophosphatemic rickets | 1.51e-04 | 25 | 22 | 3 | HP:0004912 | |
| HumanPheno | Thick lower lip vermilion | 2.30e-04 | 136 | 22 | 5 | HP:0000179 | |
| HumanPheno | Angiofibromas | 2.63e-04 | 30 | 22 | 3 | HP:0010615 | |
| HumanPheno | Hyperphosphaturia | 2.63e-04 | 30 | 22 | 3 | HP:0003109 | |
| HumanPheno | Abnormal lymphocyte apoptosis | 2.64e-04 | 6 | 22 | 2 | HP:0030886 | |
| HumanPheno | Non-medullary thyroid carcinoma | 2.64e-04 | 6 | 22 | 2 | HP:0040198 | |
| HumanPheno | Decreased lymphocyte apoptosis | 2.64e-04 | 6 | 22 | 2 | HP:0002731 | |
| HumanPheno | Cavernous hemangioma | 2.91e-04 | 31 | 22 | 3 | HP:0001048 | |
| HumanPheno | Transitional cell carcinoma of the bladder | 2.91e-04 | 31 | 22 | 3 | HP:0006740 | |
| HumanPheno | Porencephalic cyst | 3.20e-04 | 32 | 22 | 3 | HP:0002132 | |
| HumanPheno | Abnormal blood ion concentration | 3.39e-04 | 445 | 22 | 8 | HP:0003111 | |
| HumanPheno | Abnormal morphology of the vestibule of the inner ear | 3.51e-04 | 33 | 22 | 3 | HP:0011376 | |
| HumanPheno | Bladder carcinoma | 3.51e-04 | 33 | 22 | 3 | HP:0002862 | |
| HumanPheno | Congenital giant melanocytic nevus | 3.69e-04 | 7 | 22 | 2 | HP:0005600 | |
| HumanPheno | Prominence of the premaxilla | 3.69e-04 | 7 | 22 | 2 | HP:0010759 | |
| HumanPheno | Genu recurvatum | 3.84e-04 | 34 | 22 | 3 | HP:0002816 | |
| HumanPheno | Abnormality of dental color | 3.84e-04 | 34 | 22 | 3 | HP:0011073 | |
| HumanPheno | Bladder neoplasm | 3.84e-04 | 34 | 22 | 3 | HP:0009725 | |
| HumanPheno | Abnormal urine phosphate concentration | 4.19e-04 | 35 | 22 | 3 | HP:0012599 | |
| HumanPheno | Abnormal lower lip morphology | 4.24e-04 | 242 | 22 | 6 | HP:0000178 | |
| HumanPheno | Prominent lips | 4.36e-04 | 156 | 22 | 5 | HP:0000184 | |
| HumanPheno | Curly hair | 4.55e-04 | 36 | 22 | 3 | HP:0002212 | |
| HumanPheno | Enlarged thorax | 6.17e-04 | 94 | 22 | 4 | HP:0100625 | |
| HumanPheno | Hyperextensibility of the knee | 6.23e-04 | 40 | 22 | 3 | HP:0010500 | |
| HumanPheno | Pineal cyst | 6.29e-04 | 9 | 22 | 2 | HP:0012683 | |
| HumanPheno | Hypoplasia of the zygomatic bone | 7.20e-04 | 42 | 22 | 3 | HP:0010669 | |
| HumanPheno | Lymphangiectasis | 7.85e-04 | 10 | 22 | 2 | HP:0031842 | |
| HumanPheno | Sporadic | 8.71e-04 | 103 | 22 | 4 | HP:0003745 | |
| HumanPheno | Thick vermilion border | 9.06e-04 | 279 | 22 | 6 | HP:0012471 | |
| HumanPheno | Numerous nevi | 9.57e-04 | 11 | 22 | 2 | HP:0001054 | |
| HumanPheno | Precocious puberty | 9.76e-04 | 186 | 22 | 5 | HP:0000826 | |
| HumanPheno | Abnormal urine anion concentration | 1.00e-03 | 47 | 22 | 3 | HP:0011866 | |
| HumanPheno | Rickets | 1.00e-03 | 47 | 22 | 3 | HP:0002748 | |
| HumanPheno | Hemiparesis | 1.04e-03 | 108 | 22 | 4 | HP:0001269 | |
| HumanPheno | Early onset of sexual maturation | 1.05e-03 | 189 | 22 | 5 | HP:0100000 | |
| HumanPheno | Abnormal pineal morphology | 1.14e-03 | 12 | 22 | 2 | HP:0012681 | |
| HumanPheno | Abnormality of the premaxilla | 1.14e-03 | 12 | 22 | 2 | HP:0010758 | |
| HumanPheno | Fetal neck anomaly | 1.15e-03 | 111 | 22 | 4 | HP:0025667 | |
| HumanPheno | Kyphoscoliosis | 1.24e-03 | 196 | 22 | 5 | HP:0002751 | |
| Domain | Copine | 2.61e-06 | 9 | 60 | 3 | PF07002 | |
| Domain | Copine | 2.61e-06 | 9 | 60 | 3 | IPR010734 | |
| Domain | Relaxin_rcpt | 1.01e-05 | 2 | 60 | 2 | IPR008112 | |
| Domain | Olfact_rcpt | 3.52e-05 | 393 | 60 | 8 | IPR000725 | |
| Domain | GPCR_Rhodpsn_7TM | OR1N2 OR51A4 OR51A2 RXFP2 OR10V1 OR10A6 OR1K1 OR5A1 RXFP1 OR1L3 | 4.92e-05 | 670 | 60 | 10 | IPR017452 |
| Domain | 7tm_1 | OR1N2 OR51A4 OR51A2 RXFP2 OR10V1 OR10A6 OR1K1 OR5A1 RXFP1 OR1L3 | 5.37e-05 | 677 | 60 | 10 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR1N2 OR51A4 OR51A2 RXFP2 OR10V1 OR10A6 OR1K1 OR5A1 RXFP1 OR1L3 | 5.92e-05 | 685 | 60 | 10 | PS00237 |
| Domain | Solute_trans_a | 6.06e-05 | 4 | 60 | 2 | PF03619 | |
| Domain | Ostalpha/TMEM184C | 6.06e-05 | 4 | 60 | 2 | IPR005178 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR1N2 OR51A4 OR51A2 RXFP2 OR10V1 OR10A6 OR1K1 OR5A1 RXFP1 OR1L3 | 6.37e-05 | 691 | 60 | 10 | PS50262 |
| Domain | GPCR_Rhodpsn | OR1N2 OR51A4 OR51A2 RXFP2 OR10V1 OR10A6 OR1K1 OR5A1 RXFP1 OR1L3 | 6.45e-05 | 692 | 60 | 10 | IPR000276 |
| Domain | MCT | 1.01e-04 | 5 | 60 | 2 | IPR004743 | |
| Domain | RAS | 1.92e-04 | 35 | 60 | 3 | PS51421 | |
| Domain | Small_GTPase_Ras | 2.27e-04 | 37 | 60 | 3 | IPR020849 | |
| Domain | Na/solute_symporter_CS | 2.81e-04 | 8 | 60 | 2 | IPR018212 | |
| Domain | LDLR_class-A_CS | 2.86e-04 | 40 | 60 | 3 | IPR023415 | |
| Domain | Ldl_recept_a | 4.06e-04 | 45 | 60 | 3 | PF00057 | |
| Domain | - | 4.34e-04 | 46 | 60 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 4.92e-04 | 48 | 60 | 3 | PS01209 | |
| Domain | LDLRA_2 | 5.23e-04 | 49 | 60 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 5.23e-04 | 49 | 60 | 3 | IPR002172 | |
| Domain | LDLa | 5.23e-04 | 49 | 60 | 3 | SM00192 | |
| Domain | NA_SOLUT_SYMP_1 | 5.48e-04 | 11 | 60 | 2 | PS00456 | |
| Domain | NA_SOLUT_SYMP_2 | 6.56e-04 | 12 | 60 | 2 | PS00457 | |
| Domain | SSF | 6.56e-04 | 12 | 60 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 6.56e-04 | 12 | 60 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 6.56e-04 | 12 | 60 | 2 | PS50283 | |
| Domain | C2_dom | 1.91e-03 | 164 | 60 | 4 | IPR000008 | |
| Domain | MFS_1 | 1.95e-03 | 77 | 60 | 3 | PF07690 | |
| Domain | MFS | 1.95e-03 | 77 | 60 | 3 | IPR011701 | |
| Domain | VWFA | 2.33e-03 | 82 | 60 | 3 | PS50234 | |
| Domain | VWA | 2.50e-03 | 84 | 60 | 3 | SM00327 | |
| Domain | VWF_A | 3.97e-03 | 99 | 60 | 3 | IPR002035 | |
| Domain | MFS | 5.07e-03 | 108 | 60 | 3 | PS50850 | |
| Domain | 7TM_GPCR_Srsx | 5.60e-03 | 112 | 60 | 3 | SM01381 | |
| Domain | ABC_transporter_CS | 8.05e-03 | 42 | 60 | 2 | IPR017871 | |
| Domain | C2 | 8.62e-03 | 131 | 60 | 3 | PF00168 | |
| Domain | MFS_dom | 9.17e-03 | 134 | 60 | 3 | IPR020846 | |
| Domain | Ras | 9.55e-03 | 136 | 60 | 3 | PF00071 | |
| Domain | - | 9.69e-03 | 746 | 60 | 7 | 3.40.50.300 | |
| Domain | C2 | 9.74e-03 | 137 | 60 | 3 | SM00239 | |
| Domain | ABC_tran | 1.04e-02 | 48 | 60 | 2 | PF00005 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 8.86e-08 | 14 | 45 | 4 | M47390 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 1.21e-07 | 15 | 45 | 4 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.21e-07 | 15 | 45 | 4 | M47475 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 3.03e-07 | 5 | 45 | 3 | M26921 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 3.39e-07 | 19 | 45 | 4 | M47793 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 5.02e-07 | 50 | 45 | 5 | M39822 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 6.04e-07 | 6 | 45 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 6.04e-07 | 6 | 45 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 6.04e-07 | 6 | 45 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 6.04e-07 | 6 | 45 | 3 | M47932 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 1.05e-06 | 7 | 45 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 1.05e-06 | 7 | 45 | 3 | M19489 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 1.09e-06 | 25 | 45 | 4 | M39794 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 1.68e-06 | 8 | 45 | 3 | M47935 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 1.68e-06 | 8 | 45 | 3 | M27919 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 1.75e-06 | 28 | 45 | 4 | M39572 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 2.52e-06 | 9 | 45 | 3 | M47391 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 2.52e-06 | 9 | 45 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 2.52e-06 | 9 | 45 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 2.52e-06 | 9 | 45 | 3 | M27904 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 2.73e-06 | 70 | 45 | 5 | M13266 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 2.77e-06 | 126 | 45 | 6 | M16763 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 3.85e-06 | 75 | 45 | 5 | M27874 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 3.92e-06 | 34 | 45 | 4 | M48081 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 4.93e-06 | 11 | 45 | 3 | M27740 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 4.93e-06 | 11 | 45 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.93e-06 | 11 | 45 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.93e-06 | 11 | 45 | 3 | M47371 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 4.93e-06 | 11 | 45 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 4.93e-06 | 11 | 45 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 4.93e-06 | 11 | 45 | 3 | M47432 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 4.93e-06 | 11 | 45 | 3 | M27911 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 4.95e-06 | 36 | 45 | 4 | M271 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 5.48e-06 | 417 | 45 | 9 | M4072 | |
| Pathway | REACTOME_FLT3_SIGNALING | 6.18e-06 | 38 | 45 | 4 | M29803 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 6.55e-06 | 12 | 45 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 6.55e-06 | 12 | 45 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 6.55e-06 | 12 | 45 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 6.55e-06 | 12 | 45 | 3 | M39408 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 6.75e-06 | 84 | 45 | 5 | M39839 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 8.50e-06 | 13 | 45 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 8.50e-06 | 13 | 45 | 3 | M1441 | |
| Pathway | KEGG_PROSTATE_CANCER | 8.97e-06 | 89 | 45 | 5 | M13191 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 1.08e-05 | 14 | 45 | 3 | M27734 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.08e-05 | 14 | 45 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 1.08e-05 | 14 | 45 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.08e-05 | 14 | 45 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.08e-05 | 14 | 45 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 1.08e-05 | 14 | 45 | 3 | M569 | |
| Pathway | PID_TCR_RAS_PATHWAY | 1.08e-05 | 14 | 45 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.08e-05 | 14 | 45 | 3 | M47488 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 1.08e-05 | 14 | 45 | 3 | M27908 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 1.08e-05 | 14 | 45 | 3 | M719 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 1.35e-05 | 15 | 45 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.35e-05 | 15 | 45 | 3 | M47531 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | MBTPS1 SLC26A3 SLC16A3 ABCA12 ABCC11 ATP13A5 ANO3 SLC2A1 SLC16A8 SLC5A3 SLC5A4 | 1.45e-05 | 736 | 45 | 11 | M27287 |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.65e-05 | 16 | 45 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.65e-05 | 16 | 45 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.65e-05 | 16 | 45 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 1.65e-05 | 16 | 45 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 1.65e-05 | 16 | 45 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 1.65e-05 | 16 | 45 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 1.65e-05 | 16 | 45 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 1.65e-05 | 16 | 45 | 3 | M47483 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.65e-05 | 16 | 45 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 1.65e-05 | 16 | 45 | 3 | M47682 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.87e-05 | 50 | 45 | 4 | M553 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 2.00e-05 | 17 | 45 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 2.00e-05 | 17 | 45 | 3 | M47684 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 2.00e-05 | 17 | 45 | 3 | M27918 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 2.19e-05 | 52 | 45 | 4 | M19877 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 2.40e-05 | 18 | 45 | 3 | M27518 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 2.40e-05 | 18 | 45 | 3 | M39737 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 2.40e-05 | 18 | 45 | 3 | M657 | |
| Pathway | REACTOME_TIE2_SIGNALING | 2.40e-05 | 18 | 45 | 3 | M11932 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR1N2 OR51A4 OR51A2 TAS2R10 OR10V1 OR1P1 OR10A6 OR1K1 OR5A1 OR1L3 | 2.48e-05 | 636 | 45 | 10 | M41834 |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 2.52e-05 | 110 | 45 | 5 | M39492 | |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 2.55e-05 | 54 | 45 | 4 | M19818 | |
| Pathway | PID_IL2_1PATHWAY | 2.74e-05 | 55 | 45 | 4 | M122 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 2.76e-05 | 389 | 45 | 8 | M14091 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 2.84e-05 | 19 | 45 | 3 | M559 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 2.84e-05 | 19 | 45 | 3 | M27423 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 2.84e-05 | 19 | 45 | 3 | M41732 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 3.16e-05 | 57 | 45 | 4 | M19888 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 3.34e-05 | 20 | 45 | 3 | M12256 | |
| Pubmed | 9.15e-12 | 4 | 62 | 4 | 10490827 | ||
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 5.39e-09 | 3 | 62 | 3 | 28116986 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 5.39e-09 | 3 | 62 | 3 | 37013448 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 5.39e-09 | 3 | 62 | 3 | 19101897 | |
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 25977330 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 33620658 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 5.39e-09 | 3 | 62 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 5.39e-09 | 3 | 62 | 3 | 7776260 | |
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 5.39e-09 | 3 | 62 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 5.39e-09 | 3 | 62 | 3 | 26253102 | |
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 16573741 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 25788415 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 5.39e-09 | 3 | 62 | 3 | 20090846 | |
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 5.39e-09 | 3 | 62 | 3 | 26799184 | |
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 21737741 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 5.39e-09 | 3 | 62 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 5.39e-09 | 3 | 62 | 3 | 23240926 | |
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 17943694 | ||
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 5.39e-09 | 3 | 62 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 5.39e-09 | 3 | 62 | 3 | 17712732 | |
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 24222113 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 5.39e-09 | 3 | 62 | 3 | 16761621 | |
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 5.39e-09 | 3 | 62 | 3 | 22945650 | |
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 19303097 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 5.39e-09 | 3 | 62 | 3 | 20150643 | |
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 20971740 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 27119512 | ||
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 5.39e-09 | 3 | 62 | 3 | 9334313 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 2.16e-08 | 4 | 62 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 2.16e-08 | 4 | 62 | 3 | 29502968 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 2.16e-08 | 4 | 62 | 3 | 7972015 | |
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 2.16e-08 | 4 | 62 | 3 | 25999467 | |
| Pubmed | 2.16e-08 | 4 | 62 | 3 | 10085069 | ||
| Pubmed | 2.16e-08 | 4 | 62 | 3 | 38849523 | ||
| Pubmed | 2.16e-08 | 4 | 62 | 3 | 34948093 | ||
| Pubmed | 2.16e-08 | 4 | 62 | 3 | 9674433 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 2.16e-08 | 4 | 62 | 3 | 20080631 | |
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 2.16e-08 | 4 | 62 | 3 | 28117393 | |
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 22982107 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 5.38e-08 | 5 | 62 | 3 | 34535655 | |
| Pubmed | Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. | 5.38e-08 | 5 | 62 | 3 | 10498879 | |
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 9069260 | ||
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 5.38e-08 | 5 | 62 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 5.38e-08 | 5 | 62 | 3 | 15558479 | |
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 9753431 | ||
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 21072204 | ||
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 10882715 | ||
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 1.07e-07 | 6 | 62 | 3 | 29615452 | |
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 1.07e-07 | 6 | 62 | 3 | 31337872 | |
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 19487299 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 20526288 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 20179099 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 20012784 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 9690470 | ||
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 1.88e-07 | 7 | 62 | 3 | 35904492 | |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 1.88e-07 | 7 | 62 | 3 | 11948427 | |
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 20860430 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 22199277 | ||
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 15064703 | ||
| Pubmed | Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. | 3.00e-07 | 8 | 62 | 3 | 20150892 | |
| Pubmed | 4.50e-07 | 9 | 62 | 3 | 9430674 | ||
| Pubmed | 4.50e-07 | 9 | 62 | 3 | 9344703 | ||
| Pubmed | 4.50e-07 | 9 | 62 | 3 | 10783161 | ||
| Pubmed | 6.42e-07 | 10 | 62 | 3 | 34215617 | ||
| Pubmed | Desmoplakin maintains gap junctions by inhibiting Ras/MAPK and lysosomal degradation of connexin-43. | 6.42e-07 | 10 | 62 | 3 | 29959233 | |
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 8.81e-07 | 11 | 62 | 3 | 28263956 | |
| Pubmed | 1.17e-06 | 12 | 62 | 3 | 9269777 | ||
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 1.17e-06 | 12 | 62 | 3 | 9297626 | |
| Pubmed | 1.94e-06 | 14 | 62 | 3 | 25359213 | ||
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 23831572 | ||
| Pubmed | The Ras branch of small GTPases: Ras family members don't fall far from the tree. | 2.42e-06 | 15 | 62 | 3 | 10712923 | |
| Pubmed | Novel RFLPs at protooncogene and cancer-related gene loci on mouse chromosomes. | 2.97e-06 | 16 | 62 | 3 | 8095010 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 19789336 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16624289 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 27698462 | ||
| Pubmed | Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck. | 3.13e-06 | 2 | 62 | 2 | 31960612 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 1970154 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 20188103 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 33053566 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 33544116 | ||
| Pubmed | Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents. | 3.13e-06 | 2 | 62 | 2 | 14688017 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 20371679 | ||
| Pubmed | The prominent pervasive oncogenic role and tissue specific permissiveness of RAS gene mutations. | 3.13e-06 | 2 | 62 | 2 | 39455841 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 26049686 | ||
| Pubmed | Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients. | 3.13e-06 | 2 | 62 | 2 | 29921458 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28939768 | ||
| Pubmed | Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia. | 3.13e-06 | 2 | 62 | 2 | 24737308 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17210246 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 39273371 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 25009008 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28859058 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 25227306 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28703285 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17332249 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 21199217 | ||
| Interaction | HEPH interactions | 4.04e-07 | 6 | 56 | 3 | int:HEPH | |
| Interaction | SLC5A3 interactions | 7.92e-07 | 62 | 56 | 5 | int:SLC5A3 | |
| Interaction | TRPV2 interactions | 2.41e-06 | 10 | 56 | 3 | int:TRPV2 | |
| Interaction | GTSF1 interactions | 4.39e-06 | 12 | 56 | 3 | int:GTSF1 | |
| Interaction | ITGB6 interactions | 7.24e-06 | 14 | 56 | 3 | int:ITGB6 | |
| Interaction | ELMOD3 interactions | 1.11e-05 | 16 | 56 | 3 | int:ELMOD3 | |
| Interaction | SAMSN1 interactions | 1.11e-05 | 16 | 56 | 3 | int:SAMSN1 | |
| Interaction | GYPC interactions | 1.91e-05 | 19 | 56 | 3 | int:GYPC | |
| Interaction | SLC29A1 interactions | 2.15e-05 | 121 | 56 | 5 | int:SLC29A1 | |
| Interaction | SUSD5 interactions | 2.24e-05 | 20 | 56 | 3 | int:SUSD5 | |
| Interaction | SLC6A9 interactions | 2.24e-05 | 20 | 56 | 3 | int:SLC6A9 | |
| Interaction | EBF3 interactions | 3.01e-05 | 22 | 56 | 3 | int:EBF3 | |
| Interaction | NECTIN1 interactions | 3.01e-05 | 22 | 56 | 3 | int:NECTIN1 | |
| Interaction | SLC12A7 interactions | 3.26e-05 | 132 | 56 | 5 | int:SLC12A7 | |
| Interaction | SLC23A2 interactions | 3.46e-05 | 23 | 56 | 3 | int:SLC23A2 | |
| Interaction | ICMT interactions | 3.60e-05 | 67 | 56 | 4 | int:ICMT | |
| Interaction | TMEM161A interactions | 4.28e-05 | 70 | 56 | 4 | int:TMEM161A | |
| Interaction | ZDHHC18 interactions | 5.32e-05 | 74 | 56 | 4 | int:ZDHHC18 | |
| Interaction | PDLIM4 interactions | 5.67e-05 | 27 | 56 | 3 | int:PDLIM4 | |
| Interaction | CARMIL2 interactions | 6.34e-05 | 28 | 56 | 3 | int:CARMIL2 | |
| Interaction | RGL2 interactions | 6.34e-05 | 28 | 56 | 3 | int:RGL2 | |
| Interaction | SLC35A2 interactions | 7.05e-05 | 29 | 56 | 3 | int:SLC35A2 | |
| Interaction | LRRC8D interactions | 7.05e-05 | 29 | 56 | 3 | int:LRRC8D | |
| Interaction | DCUN1D3 interactions | 7.05e-05 | 29 | 56 | 3 | int:DCUN1D3 | |
| Interaction | TPD52L2 interactions | 7.24e-05 | 156 | 56 | 5 | int:TPD52L2 | |
| Interaction | SLITRK2 interactions | 7.54e-05 | 5 | 56 | 2 | int:SLITRK2 | |
| Interaction | SLC1A4 interactions | 7.82e-05 | 30 | 56 | 3 | int:SLC1A4 | |
| Interaction | CD276 interactions | 7.82e-05 | 30 | 56 | 3 | int:CD276 | |
| Interaction | JAM3 interactions | 8.64e-05 | 31 | 56 | 3 | int:JAM3 | |
| Interaction | DCBLD1 interactions | 8.64e-05 | 31 | 56 | 3 | int:DCBLD1 | |
| Interaction | PLEKHO1 interactions | 8.75e-05 | 84 | 56 | 4 | int:PLEKHO1 | |
| Interaction | MEAK7 interactions | 9.52e-05 | 32 | 56 | 3 | int:MEAK7 | |
| Interaction | CHMP6 interactions | 1.05e-04 | 33 | 56 | 3 | int:CHMP6 | |
| Interaction | LRRC57 interactions | 1.25e-04 | 35 | 56 | 3 | int:LRRC57 | |
| Interaction | SLC2A3 interactions | 1.25e-04 | 35 | 56 | 3 | int:SLC2A3 | |
| Interaction | WLS interactions | 1.30e-04 | 93 | 56 | 4 | int:WLS | |
| Interaction | ZDHHC20 interactions | 1.36e-04 | 36 | 56 | 3 | int:ZDHHC20 | |
| Interaction | TMEM94 interactions | 1.36e-04 | 36 | 56 | 3 | int:TMEM94 | |
| Interaction | ABHD5 interactions | 1.36e-04 | 36 | 56 | 3 | int:ABHD5 | |
| Interaction | TMEM87A interactions | 1.70e-04 | 187 | 56 | 5 | int:TMEM87A | |
| Interaction | EPB41L1 interactions | 1.70e-04 | 187 | 56 | 5 | int:EPB41L1 | |
| Interaction | PCDH9 interactions | 1.73e-04 | 39 | 56 | 3 | int:PCDH9 | |
| Interaction | NDRG3 interactions | 1.87e-04 | 40 | 56 | 3 | int:NDRG3 | |
| Interaction | TRPM4 interactions | 1.87e-04 | 40 | 56 | 3 | int:TRPM4 | |
| Interaction | RHBDD2 interactions | 2.07e-04 | 105 | 56 | 4 | int:RHBDD2 | |
| Interaction | RARS2 interactions | 2.07e-04 | 105 | 56 | 4 | int:RARS2 | |
| Interaction | CPNE8 interactions | 2.07e-04 | 105 | 56 | 4 | int:CPNE8 | |
| Interaction | C2orf72 interactions | 2.10e-04 | 8 | 56 | 2 | int:C2orf72 | |
| Interaction | ATP2B4 interactions | 2.11e-04 | 196 | 56 | 5 | int:ATP2B4 | |
| Interaction | SLC7A1 interactions | 2.16e-04 | 197 | 56 | 5 | int:SLC7A1 | |
| Interaction | PPFIBP2 interactions | 2.32e-04 | 43 | 56 | 3 | int:PPFIBP2 | |
| Interaction | SFT2D1 interactions | 2.32e-04 | 43 | 56 | 3 | int:SFT2D1 | |
| Interaction | NAV2 interactions | 2.32e-04 | 43 | 56 | 3 | int:NAV2 | |
| Interaction | TMEM237 interactions | 2.43e-04 | 202 | 56 | 5 | int:TMEM237 | |
| Interaction | ZDHHC5 interactions | 2.57e-04 | 111 | 56 | 4 | int:ZDHHC5 | |
| Interaction | HSP90AB2P interactions | 2.57e-04 | 111 | 56 | 4 | int:HSP90AB2P | |
| Interaction | ITM2B interactions | 2.66e-04 | 112 | 56 | 4 | int:ITM2B | |
| Interaction | NHSL3 interactions | 2.75e-04 | 113 | 56 | 4 | int:NHSL3 | |
| Interaction | SLCO4A1 interactions | 2.83e-04 | 46 | 56 | 3 | int:SLCO4A1 | |
| Interaction | TMEM230 interactions | 2.83e-04 | 46 | 56 | 3 | int:TMEM230 | |
| Interaction | TMEM165 interactions | 3.04e-04 | 116 | 56 | 4 | int:TMEM165 | |
| Interaction | PLSCR3 interactions | 3.22e-04 | 48 | 56 | 3 | int:PLSCR3 | |
| Interaction | ZBTB12 interactions | 3.36e-04 | 10 | 56 | 2 | int:ZBTB12 | |
| Interaction | ZDHHC9 interactions | 3.42e-04 | 49 | 56 | 3 | int:ZDHHC9 | |
| Interaction | PHLDB1 interactions | 3.42e-04 | 49 | 56 | 3 | int:PHLDB1 | |
| Interaction | FRK interactions | 3.63e-04 | 50 | 56 | 3 | int:FRK | |
| Interaction | DOCK8 interactions | 3.80e-04 | 123 | 56 | 4 | int:DOCK8 | |
| Interaction | ABCC5 interactions | 3.85e-04 | 51 | 56 | 3 | int:ABCC5 | |
| Interaction | CCNY interactions | 3.85e-04 | 51 | 56 | 3 | int:CCNY | |
| Interaction | RASSF5 interactions | 4.08e-04 | 52 | 56 | 3 | int:RASSF5 | |
| Interaction | CT55 interactions | 4.08e-04 | 52 | 56 | 3 | int:CT55 | |
| Interaction | HSP90AB4P interactions | 4.16e-04 | 126 | 56 | 4 | int:HSP90AB4P | |
| Interaction | BAIAP2L1 interactions | 4.55e-04 | 129 | 56 | 4 | int:BAIAP2L1 | |
| Interaction | SLC12A4 interactions | 4.55e-04 | 129 | 56 | 4 | int:SLC12A4 | |
| Interaction | HBZ interactions | 4.56e-04 | 54 | 56 | 3 | int:HBZ | |
| Interaction | RALGPS2 interactions | 4.56e-04 | 54 | 56 | 3 | int:RALGPS2 | |
| Interaction | RAB23 interactions | 4.56e-04 | 54 | 56 | 3 | int:RAB23 | |
| Interaction | EFNB3 interactions | 4.81e-04 | 55 | 56 | 3 | int:EFNB3 | |
| Interaction | RAP2C interactions | 4.81e-04 | 55 | 56 | 3 | int:RAP2C | |
| Interaction | BLID interactions | 4.92e-04 | 12 | 56 | 2 | int:BLID | |
| Interaction | CCIN interactions | 4.92e-04 | 12 | 56 | 2 | int:CCIN | |
| Interaction | PLCD1 interactions | 5.08e-04 | 56 | 56 | 3 | int:PLCD1 | |
| Interaction | LLGL2 interactions | 5.10e-04 | 133 | 56 | 4 | int:LLGL2 | |
| Interaction | CD44 interactions | 5.25e-04 | 239 | 56 | 5 | int:CD44 | |
| Interaction | CYP51A1 interactions | 5.25e-04 | 134 | 56 | 4 | int:CYP51A1 | |
| Interaction | EHBP1L1 interactions | 5.35e-04 | 57 | 56 | 3 | int:EHBP1L1 | |
| Interaction | SLC4A2 interactions | 5.40e-04 | 135 | 56 | 4 | int:SLC4A2 | |
| Interaction | FAM110C interactions | 5.80e-04 | 13 | 56 | 2 | int:FAM110C | |
| Interaction | RASGRP2 interactions | 5.80e-04 | 13 | 56 | 2 | int:RASGRP2 | |
| Interaction | RCE1 interactions | 5.80e-04 | 13 | 56 | 2 | int:RCE1 | |
| Interaction | HM13 interactions | 5.87e-04 | 138 | 56 | 4 | int:HM13 | |
| Interaction | USP53 interactions | 5.87e-04 | 138 | 56 | 4 | int:USP53 | |
| Interaction | PIK3CG interactions | 5.92e-04 | 59 | 56 | 3 | int:PIK3CG | |
| Interaction | DHRS7 interactions | 6.03e-04 | 139 | 56 | 4 | int:DHRS7 | |
| Interaction | ACSL4 interactions | 6.19e-04 | 140 | 56 | 4 | int:ACSL4 | |
| Interaction | MARVELD2 interactions | 6.22e-04 | 60 | 56 | 3 | int:MARVELD2 | |
| Interaction | F11R interactions | 6.22e-04 | 60 | 56 | 3 | int:F11R | |
| Interaction | GRK6 interactions | 6.36e-04 | 141 | 56 | 4 | int:GRK6 | |
| Interaction | NR2C2AP interactions | 6.75e-04 | 14 | 56 | 2 | int:NR2C2AP | |
| Interaction | RLN2 interactions | 6.75e-04 | 14 | 56 | 2 | int:RLN2 | |
| Cytoband | 9q33.2 | 2.07e-05 | 39 | 62 | 3 | 9q33.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 8.46e-04 | 136 | 62 | 3 | chr16q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 8.83e-04 | 138 | 62 | 3 | chr9q33 | |
| Cytoband | 16q24.3 | 2.28e-03 | 52 | 62 | 2 | 16q24.3 | |
| Cytoband | 11p15.4 | 2.55e-03 | 200 | 62 | 3 | 11p15.4 | |
| GeneFamily | Copines | 1.76e-06 | 9 | 51 | 3 | 829 | |
| GeneFamily | Olfactory receptors, family 1 | 4.76e-06 | 40 | 51 | 4 | 147 | |
| GeneFamily | Relaxin family peptide receptors | 4.66e-05 | 4 | 51 | 2 | 217 | |
| GeneFamily | RAS type GTPase family | 8.99e-05 | 31 | 51 | 3 | 389 | |
| GeneFamily | Solute carriers | 1.14e-04 | 395 | 51 | 7 | 752 | |
| GeneFamily | Olfactory receptors, family 51 | 6.84e-03 | 44 | 51 | 2 | 164 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 6.18e-06 | 416 | 51 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_200 | 2.55e-05 | 24 | 51 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k2 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 4.81e-06 | 180 | 61 | 5 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.26e-06 | 190 | 61 | 5 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| Computational | Genes in the cancer module 186. | 3.78e-05 | 20 | 36 | 3 | MODULE_186 | |
| Computational | Genes in the cancer module 71. | 5.09e-05 | 22 | 36 | 3 | MODULE_71 | |
| Drug | L 744832 | 7.31e-08 | 4 | 61 | 3 | ctd:C096898 | |
| Drug | AC1L32OA | 1.52e-06 | 9 | 61 | 3 | CID000107745 | |
| Drug | Pemetrexed | 4.84e-06 | 42 | 61 | 4 | ctd:D000068437 | |
| Drug | isoprene | 7.06e-06 | 2 | 61 | 2 | ctd:C005059 | |
| Drug | Tetranitromethane | 2.11e-05 | 3 | 61 | 2 | ctd:D013774 | |
| Drug | GGTI 2147 | 2.11e-05 | 3 | 61 | 2 | ctd:C466792 | |
| Drug | Saponins | 2.17e-05 | 61 | 61 | 4 | ctd:D012503 | |
| Disease | Hemimegalencephaly | 2.01e-10 | 6 | 58 | 4 | C0431391 | |
| Disease | Verrucous epidermal nevus | 7.21e-09 | 3 | 58 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 7.21e-09 | 3 | 58 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 7.21e-09 | 3 | 58 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 7.21e-09 | 3 | 58 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 7.21e-09 | 3 | 58 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 7.21e-09 | 3 | 58 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 7.21e-09 | 3 | 58 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 7.21e-09 | 3 | 58 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 7.21e-09 | 3 | 58 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Linear Verrucous Epidermal Nevus | 7.21e-09 | 3 | 58 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 7.21e-09 | 3 | 58 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL (disorder) | 7.19e-08 | 5 | 58 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 7.19e-08 | 5 | 58 | 3 | C0206682 | |
| Disease | RASopathy (implicated_via_orthology) | 6.00e-07 | 9 | 58 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 9.44e-07 | 38 | 58 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | Noonan Syndrome 1 | 1.18e-06 | 11 | 58 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 1.18e-06 | 11 | 58 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.18e-06 | 11 | 58 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 1.18e-06 | 11 | 58 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | Malformations of Cortical Development | 2.58e-06 | 14 | 58 | 3 | C1955869 | |
| Disease | Cortical Dysplasia | 2.58e-06 | 14 | 58 | 3 | C0431380 | |
| Disease | RASopathy | 3.22e-06 | 15 | 58 | 3 | cv:C5555857 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 3.80e-06 | 2 | 58 | 2 | 614470 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 3.80e-06 | 2 | 58 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 3.80e-06 | 2 | 58 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 3.80e-06 | 2 | 58 | 2 | 137550 | |
| Disease | Melanocytic nevus | 3.80e-06 | 2 | 58 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 3.80e-06 | 2 | 58 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 3.80e-06 | 2 | 58 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Large congenital melanocytic nevus | 3.80e-06 | 2 | 58 | 2 | cv:C1842036 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 6.83e-06 | 19 | 58 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 6.83e-06 | 19 | 58 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 6.83e-06 | 19 | 58 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 6.83e-06 | 19 | 58 | 3 | C0587248 | |
| Disease | leukemia (implicated_via_orthology) | 6.83e-06 | 19 | 58 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | Neoplastic Cell Transformation | 8.09e-06 | 139 | 58 | 5 | C0007621 | |
| Disease | LEOPARD Syndrome | 1.08e-05 | 22 | 58 | 3 | C0175704 | |
| Disease | stomatocytic anemia | 1.14e-05 | 3 | 58 | 2 | C0272048 | |
| Disease | Stomatocytosis Result | 1.14e-05 | 3 | 58 | 2 | C0677598 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 1.14e-05 | 3 | 58 | 2 | C1842036 | |
| Disease | nucleotide measurement | 1.32e-05 | 73 | 58 | 4 | EFO_0010513 | |
| Disease | Noonan Syndrome | 1.42e-05 | 24 | 58 | 3 | C0028326 | |
| Disease | paracentral lobule volume measurement | 1.61e-05 | 25 | 58 | 3 | EFO_0010317 | |
| Disease | NEVUS, EPIDERMAL | 2.27e-05 | 4 | 58 | 2 | 162900 | |
| Disease | Malignant neoplasm of penis | 2.27e-05 | 4 | 58 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 2.27e-05 | 4 | 58 | 2 | C0030849 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 2.27e-05 | 4 | 58 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 2.27e-05 | 4 | 58 | 2 | 109800 | |
| Disease | Epidermal nevus | 2.27e-05 | 4 | 58 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 2.27e-05 | 4 | 58 | 2 | cv:C0005684 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 2.27e-05 | 4 | 58 | 2 | cv:C4225426 | |
| Disease | Malignant tumor of cervix | 2.27e-05 | 4 | 58 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 2.27e-05 | 4 | 58 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 2.27e-05 | 4 | 58 | 2 | 188470 | |
| Disease | Papillary thyroid carcinoma | 2.53e-05 | 86 | 58 | 4 | C0238463 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 2.54e-05 | 29 | 58 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 2.82e-05 | 30 | 58 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.43e-05 | 32 | 58 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 3.77e-05 | 33 | 58 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 3.78e-05 | 5 | 58 | 2 | C4225426 | |
| Disease | Malignant neoplasm of thyroid | 3.78e-05 | 5 | 58 | 2 | C0007115 | |
| Disease | Cetuximab response | 3.78e-05 | 5 | 58 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 3.78e-05 | 5 | 58 | 2 | C0302592 | |
| Disease | Panitumumab response | 3.78e-05 | 5 | 58 | 2 | cv:CN077999 | |
| Disease | Thyroid Neoplasm | 5.34e-05 | 37 | 58 | 3 | C0040136 | |
| Disease | Pleocytosis | 5.67e-05 | 6 | 58 | 2 | C0151857 | |
| Disease | Autoimmune lymphoproliferative syndrome | 5.67e-05 | 6 | 58 | 2 | cv:CN301239 | |
| Disease | Carcinoma in situ of uterine cervix | 5.67e-05 | 6 | 58 | 2 | C0851140 | |
| Disease | seminoma (is_implicated_in) | 5.67e-05 | 6 | 58 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | Leukocytosis | 5.67e-05 | 6 | 58 | 2 | C0023518 | |
| Disease | Lymphoma | 6.76e-05 | 40 | 58 | 3 | C0024299 | |
| Disease | Multiple Myeloma | 7.83e-05 | 42 | 58 | 3 | C0026764 | |
| Disease | Thyroid cancer, follicular | 7.92e-05 | 7 | 58 | 2 | C2931367 | |
| Disease | high grade glioma (implicated_via_orthology) | 9.01e-05 | 44 | 58 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | Thyroid carcinoma | 9.01e-05 | 44 | 58 | 3 | C0549473 | |
| Disease | Alzheimer's disease biomarker measurement, brain volume measurement | 1.06e-04 | 8 | 58 | 2 | EFO_0006514, EFO_0006930 | |
| Disease | Neuroblastoma | 1.10e-04 | 47 | 58 | 3 | C0027819 | |
| Disease | Noonan syndrome | 1.35e-04 | 9 | 58 | 2 | cv:C0028326 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 1.69e-04 | 10 | 58 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | temporomandibular joint disorder | 1.69e-04 | 10 | 58 | 2 | EFO_0005279 | |
| Disease | cancer (implicated_via_orthology) | 1.84e-04 | 268 | 58 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | hair colour measurement | 1.98e-04 | 615 | 58 | 7 | EFO_0007822 | |
| Disease | entorhinal cortical volume, Alzheimer's disease biomarker measurement | 2.06e-04 | 11 | 58 | 2 | EFO_0005092, EFO_0006514 | |
| Disease | gallbladder neoplasm | 2.06e-04 | 11 | 58 | 2 | C0016978 | |
| Disease | endometriosis (implicated_via_orthology) | 2.06e-04 | 11 | 58 | 2 | DOID:289 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of gallbladder | 2.06e-04 | 11 | 58 | 2 | C0153452 | |
| Disease | Colorectal Neoplasms | 2.15e-04 | 277 | 58 | 5 | C0009404 | |
| Disease | Colonic Neoplasms | 2.31e-04 | 152 | 58 | 4 | C0009375 | |
| Disease | Malignant tumor of colon | 2.75e-04 | 159 | 58 | 4 | C0007102 | |
| Disease | carcinoma (implicated_via_orthology) | 2.76e-04 | 64 | 58 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | imidazole lactate measurement | 2.92e-04 | 13 | 58 | 2 | EFO_0800004 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 2.92e-04 | 13 | 58 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | Neoplasms, Experimental | 3.02e-04 | 66 | 58 | 3 | C0027659 | |
| Disease | Disease Exacerbation | 3.16e-04 | 165 | 58 | 4 | C0235874 | |
| Disease | whole-brain volume, Alzheimer's disease biomarker measurement | 3.40e-04 | 14 | 58 | 2 | EFO_0005089, EFO_0006514 | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.44e-04 | 69 | 58 | 3 | DOID:4450 (is_implicated_in) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.75e-04 | 71 | 58 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 3.78e-04 | 173 | 58 | 4 | C0023467 | |
| Disease | dysmenorrheic pain measurement | 4.48e-04 | 16 | 58 | 2 | EFO_0007889 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FIVFLACLGVMGFFY | 401 | Q4VNC0 | |
| EIGLMNFVLGFFCCF | 156 | Q9H305 | |
| FLDYILGGCQLMFTV | 296 | Q96FN4 | |
| GMAFITYVCVNLFFG | 2096 | Q86UK0 | |
| LFGDVAMVVEFLSCY | 606 | Q9UIG0 | |
| LCFVMEYVNGGELFF | 221 | Q9Y243 | |
| IVGLCVFFYGLFTMN | 411 | Q9BYT9 | |
| YMRTGEGFLCVFAIN | 71 | P01112 | |
| YMRTGEGFLCVFAIN | 71 | P01116 | |
| YMRTGEGFLCVFAIN | 71 | P01111 | |
| LCEMTFPYEFFARQG | 116 | Q96M98 | |
| DMVGILDFYFQLCSI | 406 | O94925 | |
| LVAFCVAFGLSYGMV | 346 | O95907 | |
| QMFFFVFLGGADCVL | 101 | Q8NGI7 | |
| GQDVIFGCEVFAYPM | 186 | Q96I82 | |
| MGYFVEVLGAPFTCF | 671 | Q14703 | |
| FIVGMCFQYVEQLCG | 416 | P11166 | |
| LVVFCIFFGISYGMV | 321 | O15427 | |
| CGFEPFYDERGDQFM | 236 | Q16566 | |
| CAEISMIGQFGVGFY | 96 | Q58FF6 | |
| IAGGLFVMDKFYFEE | 306 | Q10471 | |
| SLFVMGGVYFVCQRV | 1396 | O75197 | |
| DGFCELFGYSRVEVM | 46 | Q9H252 | |
| IFVKIFFQELCEYMG | 581 | Q9HCG8 | |
| CRLEVEFMFSYGNFG | 231 | Q53TS8 | |
| CTYLLEQIDMLFFGG | 976 | A6NKB5 | |
| AAQFFFFVGMGLSEC | 101 | Q8NGJ0 | |
| GGYMVSCIIFFFVVL | 801 | Q96J66 | |
| IDIYLMGCFVFVFLA | 306 | P18505 | |
| GQVDSLAIFYCLFEM | 546 | Q96MN2 | |
| IDVIYGFFGALCLMV | 196 | Q8NGJ7 | |
| IDVIYGFFGALCLMV | 196 | Q8NGJ6 | |
| AGCLTQMYFFFALGV | 96 | Q8NGR3 | |
| FLDYIMGGCQIQFTV | 296 | Q96A23 | |
| FLDYIMGGCQIHFTV | 371 | Q9UBL6 | |
| MGYQCFVSFFDLRDP | 116 | Q13347 | |
| FDFQAMGRIFVGLCQ | 1936 | Q14204 | |
| EFFGVAMLEAVYCGC | 371 | Q4AE62 | |
| LFYTDFMGEVVFQGD | 576 | Q9Y2W3 | |
| MYFILLFGGAECFLL | 101 | Q8NH74 | |
| ECLAQMYFFLVFGNI | 96 | Q8NH93 | |
| AQLYFLLMFGGLDNC | 116 | Q8NGR9 | |
| CLAQLYFFLTFGDMD | 111 | Q8NH06 | |
| IEFIFGVVMFGNGAY | 471 | Q8WU17 | |
| FILYFIGMAIEISCF | 236 | Q9NYW0 | |
| EAYVSGMLFCLGIFL | 291 | Q8NBJ9 | |
| AAGYQDFIICVEMFF | 291 | Q9Y519 | |
| AAGYQNFIICVEMLF | 301 | Q6ZMB5 | |
| DCLMGVYLFFVGIFD | 461 | Q8WXD0 | |
| GLFAVCSLGIFMFVY | 701 | P53794 | |
| FILMGFAFNEVGGYE | 216 | Q9NY91 | |
| GDCFGIAMVAFAVAF | 341 | P40879 | |
| VRDSCEPVMQFFGFY | 136 | Q8N474 | |
| RIVAFFEFGGVMCVE | 146 | P10415 | |
| ADFMQEVGYGFCASI | 256 | A5YKK6 | |
| KYCFEVFDLNGDGFI | 106 | Q9HAE3 | |
| DCLMGIYLFVIGGFD | 451 | Q9HBX9 | |
| MELVAGCYEQVLFGF | 1 | Q9NWT1 | |
| TVLYCGEVAFGLYMF | 41 | Q5GH77 | |
| FYKFGLEICFLMAVN | 991 | Q92508 | |
| CEFATGFLEYFDMNT | 791 | Q8IWU6 | |
| GLYVCMNTFLAFGRE | 61 | Q92995 |